Skip to content

Influence of Exercise on the Mobility and Balance of Individuals With Multiple Sclerosis

Influence of Exercise on the Mobility and Balance of Individuals With Multiple Sclerosis Influence of High-Dosage Physical Therapy on the Balance and Mobility of Individuals With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524483
Enrollment
32
Registered
2015-08-14
Start date
2014-10-01
Completion date
2015-06-01
Last updated
2023-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

Outcomes from the investigators' recent investigation suggested that a high dosage of challenging physical therapy exercises can result in clinically improvements in the postural balance and walking speed of individuals with MS. This investigation will evaluate mobility and postural balance improvements in individuals with MS who participate in a therapeutic protocol consisting of activity based exercises, and in individuals with MS that participate in challenging physical therapy protocol.

Detailed description

Background: Outcomes from the investigators' recent exploratory investigation suggested that a high dosage of challenging physical therapy exercises can result in clinically relevant improvements in the postural balance and walking speed of individuals with MS. Objective: The investigators anticipated that the promising results were due to the novel challenging postural balance and mobility exercises. The purpose of this investigation was to test this notion by evaluating the mobility and postural balance improvements that could be achieved in a cohort of individuals with MS who participated in a therapeutic protocol that consisted of activity based exercises, and a cohort of individuals with MS that participated in the challenging physical therapy protocol.

Interventions

BEHAVIORALTherapeutic Challenge Program

The Therapeutic Challenge Program will consist of a 5 minute warm-up, 20 minutes of challenging balance training, and 20 minutes of challenging treadmill and overground walking.

The Therapeutic Exercise Program will consist of 15 minutes of strength training and flexibility exercises, 15 minutes of balance exercises, and 15 minutes of treadmill walking.

Sponsors

University of Nebraska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Definitive diagnosis of multiple sclerosis * Kurtzke Expanded Disability Status of 3.0 - 6.5 * Able to walk on a treadmill at a minimum of 0.5 miles per hour while holding onto handrails * Cognitively and emotionally competent * A Mini-Mental State Examination score \> 21 * Composite score on the computerized Sensory Organization Test of \< 70

Exclusion criteria

* Documented MS-related relapse in the previous 6 months * Major MS-specific medication changes within the previous 3 months * Presence of another major co-morbidity such as neurological disorders, uncontrolled pain, hypertension, and diabetes

Design outcomes

Primary

MeasureTime frameDescription
Changes in Balance Using the Sensory Organization TestBaseline and 6 weeksThe Sensory Organization Test consists of six different conditions that measure each subject's ability to integrate visual, somatosensory, and vestibular feedback to reduce the overall amount of postural sway and improve balance.
Changes in Walking Velocity, Step Lengths, Step Widths, and CadenceBaseline and 6 weeksThe changes in walking velocity, step lengths, step widths, and cadence will be quantified using a GaitRITE digital mat.

Secondary

MeasureTime frameDescription
Changes in Endurance using the 6-Minute WalkBaseline and 6 weeksThe changes in endurance will be evaluated using the total distance walking during a 6 minute time frame.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026